Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.
about
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidasesIntegrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virusEntry of parainfluenza virus into cells as a target for interrupting childhood respiratory diseaseThe biology of influenza virusesLive attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenzaInfluenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or buddingPeramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza InfectionsModeling human influenza infection in the laboratoryRecent progress in structure-based anti-influenza drug designEmerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human ParechovirusPeramivir (BCX-1812, RWJ-270201): potential new therapy for influenzaThe anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activitiesCharacterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.Influence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 41044-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitroOral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.Evolutionary history and phylodynamics of influenza A and B neuraminidase (NA) genes inferred from large-scale sequence analysesBacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitorThe N-terminal fragment of a PB2 subunit from the influenza A virus (A/Hong Kong/156/1997 H5N1) effectively inhibits RNP activity and viral replicationDrug resistance in influenza A virus: the epidemiology and management.Characterization of the 1918 "Spanish" influenza virus neuraminidase gene.Zanamivir: a rational approach to influenza B.How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?New vaccines against influenza virus.Potential risks associated with the proposed widespread use of Tamiflu.The origin and virulence of the 1918 "Spanish" influenza virus.Strain-specific antiviral activity of iminosugars against human influenza A virusesOseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol.Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.Optimizing viral protein yield of influenza virus strain A/Vietnam/1203/2004 by modification of the neuraminidase gene.Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesPostreassortment amino acid substitutions in influenza A viruses.Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.Ultrasensitive detection of drug-resistant pandemic 2009 (H1N1) influenza A virus by rare-variant-sensitive high-resolution melting-curve analysis.Novel vaccines against influenza viruses.Virus-like particles as universal influenza vaccinesNeuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic.Polar residues and their positional context dictate the transmembrane domain interactions of influenza A neuraminidases.
P2860
Q21142689-6BA8694A-9A74-4EC0-A12C-85EBCBF32321Q24522375-7CD46385-0086-49E1-B67A-E81C6C41912FQ24530163-F7EE17DC-3FA8-47D6-B45A-DF76025B9AA9Q24620598-AC4DAD33-EEA2-46C4-9E20-BE467B1B5673Q24652088-66721D67-712A-4264-BA4E-8D1EA19D05ECQ24676721-F603340C-A44D-467F-BC2F-5FBC1028D5DBQ26749578-65506B2C-259A-467F-8093-F18CD8651A23Q26781842-DDD23D68-B4E2-4AFF-BC53-183F107FAAB9Q26863710-1E36A2B9-A703-4569-A011-0A7A67422F99Q28085230-694D6C9C-E611-469A-9EAD-598CD14CE81DQ28201381-015E9EE2-FD1F-43FC-9446-3CF22F20485DQ28344907-B3C63809-2E18-4554-A503-D22E3C188A78Q28349496-A3B44CA2-E47D-453F-B4C0-AA4485C15109Q28369317-3A404EC5-63B5-4939-8E87-2F04BCFE697FQ28372624-52EE4679-939B-49EA-A73D-56DFDEFD636FQ28378588-CB1E1A06-9C87-412A-B34D-B9B6EFDF6BD1Q28379409-68F106ED-035D-44C3-8CE1-49141F97A33DQ28481260-CBCA9373-920B-40B7-B654-B46AFF81780CQ28483824-E3A79C31-8630-41E1-BDBE-BB6D1E175044Q28542440-E3E55737-B509-4830-9C5E-29D146609FEFQ30234600-AEBAAE24-CF0B-4A8A-BE61-753D3193DEC7Q30326831-095358E8-4AF6-4860-B844-CE2B75D7AA8BQ30327955-904B4159-C481-48A4-B0CF-F1D07296B933Q30357603-2254E925-8672-4D32-9DA6-FFD33798EA10Q30357932-DB1F63D7-30A9-4F77-989C-A8B62683BA51Q30360496-66095478-D497-47CD-98A7-DA6F154029BCQ30361962-BDEC91B6-7D51-445A-AF18-7A18EB07C7FDQ30366818-805226F0-C5B5-4AD7-8E06-C7447A444B4FQ30371242-A1B08037-F1E1-42DD-BABF-C70E452A0C1EQ30372024-CBC44B20-4F13-4163-98CA-4E3A4559E112Q30374997-F8E3A08A-844E-4ACF-8AC6-CD8A575D10F9Q30380287-0377E934-80D6-44AE-BA62-A9B98C5AF635Q30386823-DF178589-2E00-42E4-A3DF-E1AE55947B0EQ30388799-4C508490-32B9-48BB-988E-2B969FB33E78Q30390818-8F22FF1E-54EE-4C14-A197-296595B9CD9BQ30402340-D57D7AB8-04DD-4C38-8961-881C704524CEQ30407716-085EEC32-0C60-41BA-8A57-65382B54931FQ30421558-3C8552EB-0424-41A0-A72C-2D14F3CD9849Q30425347-B9669650-9C3D-4E50-A981-0EF81BB00985Q30427691-E5AA4680-132D-4516-ADF4-0BA2C534D07F
P2860
Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.
description
1976 nî lūn-bûn
@nan
1976 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@ast
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@en
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@nl
type
label
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@ast
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@en
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@nl
altLabel
Inhibition of influenza virus ...... id (FANA): mechanism of action
@en
prefLabel
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@ast
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@en
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@nl
P3181
P1476
Inhibition of influenza virus ...... d (FANA): mechanism of action.
@en
P2093
P304
P3181
P356
10.1099/0022-1317-33-1-159
P407
P577
1976-10-01T00:00:00Z